Boutique Biotech

Boutique Biotech

Share this post

Boutique Biotech
Boutique Biotech
Milestone Pharmaceuticals and Astria Therapeutics in the spotlight

Milestone Pharmaceuticals and Astria Therapeutics in the spotlight

Deep-dive fundamental and technical analysis of $MIST and $ATXS

Bohdan (Bo) Khomtchouk, Ph.D.'s avatar
Bohdan (Bo) Khomtchouk, Ph.D.
Jul 11, 2022
∙ Paid

Share this post

Boutique Biotech
Boutique Biotech
Milestone Pharmaceuticals and Astria Therapeutics in the spotlight
Share

The biotech market saw the total EV of publicly traded companies continue to rise in the start of July, up by about 25% from the mid-June lows. Although fundamentals are slowly improving, the macro environment & continued rising interest rates remain a question mark as we kick-off the second half of the year.

Below are two names that we are paying attent…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Bohdan (Bo) Khomtchouk, Ph.D.
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share